Softgel Manufacturing Equipment Market Size, Share, Growth, Industry Analysis, Trends and Dynamics, By Types (Soft Capsule Encapsulation Machines, Soft Capsule Drying Systems, Other Auxiliary Devices), By Applications (Pharmaceutical, Health Supplements, Others), Regional Insights and Forecast to 2035
- Last Updated: 20-November-2026
- Base Year: 2025
- Historical Data: 2021-2024
- Region: Global
- Format: PDF
- Report ID: GGI104783
- SKU ID: 30395585
- Pages: 102
Download FREE Sample
Softgel Manufacturing Equipment Market Size
The Global Softgel Manufacturing Equipment Market size was USD 402.8 Million in 2025 and is projected to touch USD 470.76 Million in 2026 and USD 550.3 Million in 2027 to USD 1917.36 Million by 2035, exhibiting a CAGR of 16.89% during the forecast period [2026-2035].
Demand is rooted in the shift from tablets toward liquid-filled dosage forms, which now account for roughly 31% of new oral product launches that rely on bioavailability enhancement. Equipment buyers are also prioritizing throughput, and lines running above 60% automation are replacing semi-manual setups at a steady pace. Capacity additions among contract producers support this momentum, with nearly 22% of installed machines now under five years old.
![]()
In the US Softgel Manufacturing Equipment Market, growth is shaped by dietary supplement manufacturers and specialty pharmaceutical firms, which together drive about 78% of domestic equipment demand. Replacement of ageing encapsulation lines contributes close to 26% of purchases.
Key Findings
- Market Size: Starting at $470.76M in 2026, projected to touch $550.3M in 2027 to $1917.36M by 2035 at a CAGR of 16.89%.
- Growth Drivers: Supplement demand lifts orders by 34%, while automation upgrades influence 29% of purchases and bioavailability formats support 23% of pipelines.
- Trends: Plant-based shells reach 18% of new line specifications, and energy-efficient drying cuts cycle times by 15% across modern installations.
- Key Players: Changsung, SKY, Technophar, Pharmagel, GIC Engineering & more.
- Regional Insights: Asia-Pacific leads with 41% share, North America holds 27%, Europe captures 24%, and Middle East & Africa accounts for 8% of demand.
- Challenges: High capital outlay deters 37% of small producers, and skilled operator shortages affect 21% of plants adopting advanced lines.
- Industry Impact: Modern encapsulation lines reduce fill weight variation by 40% and lift yield by 12%, improving margins for pharmaceutical and supplement makers.
- Recent Developments: New rotary die platforms raised output by 25%, while smart monitoring modules reduced unplanned stoppages by 17% in recent launches.
Softgel production equipment sits at a quiet intersection of pharmaceutical engineering and consumer wellness. Encapsulation precision, shell chemistry control and drying uniformity decide product quality, and about 45% of buyer evaluations now weigh process consistency above purchase price.
Manufacturers that combine mechanical reliability with digital process control hold a visible edge. Roughly 33% of recent line purchases include integrated inspection or data logging, reflecting tighter quality expectations across regulated and semi-regulated production environments.
![]()
Softgel Manufacturing Equipment Market Trends
Automation is reshaping how softgel plants are planned. Closed-loop gel mass preparation, servo-driven injection wedges and inline weight checking are moving from premium options to baseline expectations, with about 48% of new orders specifying at least two of these features. Plants report that digital controls trim changeover time by nearly 20%, which matters for producers running many small batches of specialty formulations.
Material innovation is the second force at work. Non-gelatin and plant-based shell formulations now influence around 18% of equipment specifications, pushing builders to redesign die rolls, sealing temperatures and drying profiles. At the same time, energy-conscious drying tunnels and tumble dryer upgrades are lowering power consumption by close to 14%, while compact machines for pilot and small-batch work are gaining a 10% larger share of inquiries from nutraceutical start-ups and contract developers.
Softgel Manufacturing Equipment Market Dynamics
Growth in contract manufacturing and plant-based formats
Contract development and manufacturing organizations are expanding softgel capacity, and about 36% of them plan to add or upgrade encapsulation lines. Plant-based shell compatibility opens a further niche, with nearly 18% of new supplement launches seeking non-animal capsules. Suppliers offering flexible, quick-changeover machines can capture this demand, particularly in regions where local production share is rising by 9% as importers localize supply.
Rising demand for bioavailable supplements and pharmaceuticals
Consumers favor easy-to-swallow, fast-absorbing formats, and softgels now represent about 27% of the supplement capsule category. Pharmaceutical developers add to demand, since nearly 40% of poorly soluble drug candidates are evaluated in lipid-based fills. Higher-speed automated lines further support purchases by lifting plant output by 22% compared with legacy equipment.
| Market Driver | Impact Rank | Contribution | 2026-2028 | 2029-2031 | 2032-2035 |
|---|---|---|---|---|---|
| Rising supplement and nutraceutical softgel consumption | High | 6.4% | High | High | Medium |
| Pharmaceutical shift to lipid-based bioavailability formats | High | 5.2% | High | High | Medium |
| Automation and high-speed rotary die adoption | Medium | 4.1% | High | Medium | Medium |
| Contract manufacturing capacity expansion | Medium | 2.9% | Medium | High | Medium |
| Plant-based shell demand | Low | 1.5% | Low | Medium | Medium |
| Others | Lowest | 0.9% | Low | Low | Low |
| Total Driver Contribution | 21.0% |
RESTRAINT
"High capital cost and process complexity"
Softgel lines demand heavy upfront investment, and complete encapsulation, drying and inspection setups can consume 30% to 35% of a small producer's annual capital budget. Process complexity compounds the burden, because shell and fill compatibility problems cause nearly 11% of trial batches to fail. Validation requirements add another layer, extending commissioning timelines by about 16% and encouraging cautious buyers to postpone upgrades.
| Market Restraint | Impact Rank | Negative CAGR Impact | 2026-2028 | 2029-2031 | 2032-2035 |
|---|---|---|---|---|---|
| High capital cost and line integration complexity | High | -1.7% | High | Medium | Medium |
| Shell formulation sensitivity and skilled operator shortage | Medium | -1.2% | Medium | Medium | Low |
| Regulatory and validation burden | Low | -0.8% | Medium | Low | Low |
| Others | Lowest | -0.41% | Low | Low | Low |
| Total Restraint Impact | -4.11% |
CHALLENGE
"Skilled labor gaps and rising component costs"
Precision tooling, stainless steel components and servo systems have grown more expensive, pushing machine maintenance budgets up by roughly 13% for many plants. Skilled technicians remain scarce, and about 21% of facilities report slower startup of new lines because operators need extended training. Tight tolerance requirements also mean die roll replacement is frequent, adding to lifetime ownership costs and making smaller producers weigh refurbished equipment against new purchases.
Segmentation Analysis
Segmentation shows a market anchored by core encapsulation equipment but increasingly supported by drying and auxiliary systems. Pharmaceutical and supplement producers together account for about 84% of equipment demand, while specialty uses fill the remaining share.
By Type
Soft Capsule Encapsulation Machines
Encapsulation machines form the heart of every softgel line and hold roughly 52% of segment share. Buyers value fill accuracy, and modern rotary die systems keep weight variation within 1% to 2% while running continuously for long shifts. Upgrades from older units are frequent, with about 30% of purchases directed at replacing machines that struggle with viscous or sensitive fills.
Soft Capsule Drying Systems
Drying systems contribute near 28% of the type mix and are gaining attention as plants chase consistent shell quality. Tumble dryers paired with controlled-humidity tunnels shorten drying cycles by about 15%, while reducing deformation and sticking defects. Energy efficiency matters here, since drying can represent a considerable share of operating power on a softgel line.
Other Auxiliary Devices
Auxiliary equipment, including gel melters, inspection units, polishing machines and conveying tools, makes up about 20% of demand. Inline inspection is the fastest-moving item, with adoption rising among roughly 33% of new installations. Gel preparation vessels with tighter temperature control also help lower batch rejection by nearly 9%, supporting steadier line performance.
By Application
Pharmaceutical
Pharmaceutical producers lead with close to 46% of application demand. Softgels suit poorly soluble active ingredients, and about 40% of lipid-based formulation projects move toward this format. Buyers in this segment emphasize validation support, documentation and contamination control, so equipment with hygienic design and traceability features secures a decisive purchasing advantage.
Health Supplements
Health supplements account for roughly 38% of equipment use and show the quickest replacement and expansion cycle. Omega-3, vitamin D and herbal oil products drive volumes, with around 27% of supplement capsule launches choosing softgel form. Private-label and contract producers prefer flexible machines that handle frequent formulation changes within short production windows.
Others
Other uses, including cosmeceutical, veterinary and specialty personal care products, represent nearly 16% of demand. These buyers typically run smaller batches and favor compact machines, which now appear in about 24% of inquiries from this group. Novelty shapes and functional beauty capsules continue to widen the opportunity.
![]()
Softgel Manufacturing Equipment Market Regional Outlook
Regional demand reflects differences in manufacturing depth and consumer supplement habits. Asia-Pacific holds 41% share, North America follows with 27%, Europe contributes 24%, and Middle East & Africa accounts for 8%, together representing the full market.
North America
North America commands about 27% of global demand, supported by a large supplement industry and a strong base of contract manufacturers. Roughly 35% of regional purchases target automation upgrades, and replacement of aging lines contributes another 26%. Stringent quality expectations encourage investment in inspection and data logging, which feature in about 40% of new regional installations.
Europe
Europe represents around 24% of the market, shaped by pharmaceutical expertise and sustainability priorities. Energy-efficient drying and plant-based shell compatibility attract close to 29% of regional equipment inquiries. Strict compliance standards push about 38% of buyers toward machines with documented validation support, favoring established suppliers with strong engineering and service networks.
Asia-Pacific
Asia-Pacific leads with approximately 41% share, driven by established equipment manufacturing in Korea, China and Japan and a rapidly growing supplement sector in India and Southeast Asia. Local production accounts for nearly 55% of machines installed regionally. Capacity additions by contract producers influence about 32% of purchases, keeping the region the main growth engine.
Middle East & Africa
Middle East & Africa holds close to 8% of demand but is expanding steadily from a small base. Local pharmaceutical production initiatives influence about 34% of new equipment inquiries, while imported supplement substitution supports another 17%. Buyers favor mid-capacity, easy-to-maintain machines and often depend on supplier training to build technical capability.
List of Key Softgel Manufacturing Equipment Market Companies Profiled
- Changsung
- SKY
- Technophar
- Pharmagel
- GIC Engineering
- Sankyo
- Kamata
- Bochang
- Tooltronics
- Long March Tianmin
Top Companies with Highest Market Share
- Changsung: Holds about 17% market share through a broad encapsulation portfolio.
- SKY: Commands nearly 13% share, supported by strong rotary die and drying offerings.
Investment Analysis and Opportunities
Investment activity is centered on capacity, automation and flexibility. Around 40% of announced equipment budgets by producers are earmarked for modern encapsulation lines, while 25% targets drying and inspection upgrades that raise first-pass yield. Contract manufacturers are the most active buyers, as nearly 36% plan expansions to serve brand owners outsourcing softgel production. Opportunities also lie in emerging markets, where local manufacturing share is rising by about 9% and creates room for mid-range machines paired with training and service packages. Suppliers that offer financing, spare part availability and remote diagnostics improve conversion rates by close to 15%, and investors increasingly favor firms with recurring aftermarket income, which already contributes roughly 18% of supplier activity.
New Products Development
Product development focuses on speed, precision and adaptability. New rotary die machines raise output by about 25% over earlier generations, while servo-controlled injection systems tighten fill accuracy by nearly 30%. Quick-change die rolls reduce changeover time by around 20%, which helps contract producers handle varied orders. Developers are also designing equipment for non-gelatin shells, with about 18% of new prototypes built for plant-based compatibility. Smart modules add further value, as sensors and analytics reduce unplanned downtime by roughly 17%. Compact pilot-scale machines are another growth area, attracting nearly 24% of inquiries from start-ups and formulation laboratories testing new fills before commercial scale-up.
Five Recent Development
- March 2024– Changsung introduced a high-speed rotary encapsulation platform: The platform lifted output by about 22% versus its earlier model and cut fill weight deviation by 18%, strengthening the case for replacing older lines across the Softgel Manufacturing Equipment sector.
- July 2024– SKY expanded its drying system range: The upgraded tumble and tunnel units reduce drying time by nearly 15% and lower energy consumption by 12%, addressing rising efficiency demands among producers in the Softgel Manufacturing Equipment sector.
- November 2024– Technophar launched quick-change die roll tooling: The tooling shortens changeover by close to 20% and supports small-batch flexibility, which is valuable to the roughly 36% of contract producers expanding softgel capacity.
- February 2025– Pharmagel released plant-based shell compatible equipment: The configuration supports non-gelatin formulations and responds to the 18% of new product specifications requesting non-animal capsules, widening the addressable base for Softgel Manufacturing Equipment suppliers.
- June 2025– GIC Engineering added inline inspection and monitoring modules: The modules reduce unplanned stoppages by about 17% and improve defect detection by 25%, aligning with the 33% of new installations seeking integrated quality control.
Report Coverage
This report examines the Softgel Manufacturing Equipment Market through a structured view of demand, technology and competition. It reviews segmentation by type, covering encapsulation machines at 52%, drying systems at 28% and auxiliary devices at 20%, and by application, covering pharmaceutical at 46%, health supplements at 38% and others at 16%. Regional analysis spans North America at 27%, Europe at 24%, Asia-Pacific at 41% and Middle East & Africa at 8%. The study profiles ten manufacturers, including Changsung, SKY, Technophar, Pharmagel, GIC Engineering, Sankyo, Kamata, Bochang, Tooltronics and Long March Tianmin, and assesses their product strategies, capacity moves and service models. Coverage also includes driver and restraint ranking, with drivers contributing 21.0% and restraints reducing growth by 4.11%, along with trends in automation, plant-based shells and energy-efficient drying. Investment patterns, new product development and recent company activity round out the analysis, giving equipment suppliers, contract producers and investors a practical basis for planning.
Softgel Manufacturing Equipment Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 470.76 Million in 2026 |
|
|
Market Size Value By |
USD 1917.36 Million by 2035 |
|
|
Growth Rate |
CAGR of 16.89% from 2026 - 2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Download FREE Sample
Frequently Asked Questions
-
What value is the Softgel Manufacturing Equipment Market expected to touch by 2035?
The global Softgel Manufacturing Equipment Market is expected to reach USD 1917.36 Million by 2035.
-
What CAGR is the Softgel Manufacturing Equipment Market expected to exhibit by 2035?
The Softgel Manufacturing Equipment Market is expected to exhibit a CAGR of 16.89% by 2035.
-
Who are the top players in the Softgel Manufacturing Equipment Market?
Changsung, SKY, Technophar, Pharmagel, GIC Engineering, Sankyo, Kamata, Bochang, Tooltronics, Long March Tianmin
-
What was the value of the Softgel Manufacturing Equipment Market in 2025?
In 2025, the Softgel Manufacturing Equipment Market value stood at USD 402.8 Million.
About the Author(s):
This report was authored by the Machinery & Equipment Research Team at Global Growth Insights. The team specializes in industrial machinery, manufacturing equipment, automation, robotics, construction equipment, and heavy engineering markets. Their expertise includes market sizing, supply chain analysis, competitive assessment, and industrial technology forecasting.
Our Clients
Download FREE Sample